An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6150053)

Published in J Endocrinol Invest on August 01, 1984

Authors

T W Tao, J P Kriss

Articles by these authors

Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76

Primary-type antibody response in vitro. Science (1966) 2.82

Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92

Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67

Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66

Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65

Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39

Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36

HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33

Non-metastasising variants selected from metastasising melanoma cells. Nature (1977) 1.28

Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26

Capacity of pepsin-digested antibody to inhibit antibody formation. Nature (1966) 1.24

Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab (1970) 1.11

Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08

Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06

Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06

Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05

Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04

Carbohydrate changes in glycoproteins of a poorly metastasizing wheat germ agglutinin-resistant melanoma clone. Cancer Res (1980) 1.04

Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02

Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98

Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98

Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97

Interpolative background subtraction. J Nucl Med (1976) 0.94

Initiation of primary-type and secondary-type antibody responses to bacteriophage phiX 174 in vitro. J Immunol (1968) 0.94

Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93

In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91

The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91

Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91

Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91

Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90

Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89

Altered glycosylation of beta 1 integrins associated with reduced adhesiveness to fibronectin and laminin. Int J Cancer (1993) 0.89

HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89

Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88

The immune response of mice to phiX174. The potentiation of B-cell immunity and the suppression of T-cell help by pertussis vaccine. Immunology (1975) 0.88

Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88

Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88

Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88

Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87

Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87

Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85

Reduced cell adhesion to fibronectin and laminin is associated with altered glycosylation of beta 1 integrins in a weakly metastatic glycosylation mutant. Int J Cancer (1989) 0.85

Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85

Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85

Lectin-resistant variants of mouse melanoma cells. I. Altered metastasizing capacity and tumorigenicity. Int J Cancer (1982) 0.84

The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84

The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83

Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83

Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82

Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81

Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81

Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80

Antibody response to bacteriophage theta-X 174 in vitro: demonstration of immunological memory in terms of IgM and IgG responses. Eur J Immunol (1972) 0.80

Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80

Preparation of radiolabeled thyroid-stimulating immunoglobulins (TSI) by recombining TSI heavy chains with 125I-labeled light chains: direct evidence that the product binds to the membrane thyrotropin receptor and stimulates adenylate cyclase. Endocrinology (1978) 0.80

Stable heat-resistant clones selected from wild-type and surface variants of B-16 melanoma. Int J Cancer (1983) 0.80

Membrane lipids of B16 melanoma cells and heat-resistant variants. Int J Radiat Biol (1988) 0.80

In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79

Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79

Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79

Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79

Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78

The Zipp assay: a method for enumerating cells producing anti-phage antibody. Eur J Immunol (1972) 0.78

Heat shock protein levels are not elevated in heat-resistant B16 melanoma cells. Radiat Res (1986) 0.78

The influence of membrane mutations on metastasis. Biosci Rep (1982) 0.78

Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med (1967) 0.78

A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab (1979) 0.78

Altered adhesiveness of tumor cell surface variants with reduced metastasizing capacity--reduced adhesiveness to vascular wall components in culture. Int J Cancer (1982) 0.77

Alteration of mammalian cells by interaction with artificial lipid vesicles. Cancer Res (1976) 0.77

New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J (1974) 0.77

Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab (1967) 0.77

N-linked sugar chains of mouse B16 melanoma cells and their low-metastasizing variant selected by wheat germ agglutinin. Glycobiology (1991) 0.76

The long-acting thyroid stimulator. Calif Med (1968) 0.76

Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (1976) 0.76

Lectin-resistant variants of mouse melanoma cells. II. In vitro characteristics. Int J Cancer (1983) 0.76

Editorial: Hyperthyroidism. Calif Med (1970) 0.75

Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J (1979) 0.75

Simple evaluation of thyroid function. West J Med (1988) 0.75

Video instrumentation for radionuclide angiocardiography. Am J Cardiol (1973) 0.75

HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings]. Diabete Metab (1976) 0.75

Robert Reid Newell, 1892-1965. J Nucl Med (1966) 0.75

Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer (1976) 0.75

Degradation of C14-labeled thymidine and its halogenated analogues in man. Adv Tracer Methodol (1966) 0.75

Guidelines and criteria for a committee authorizing the use of radioactive isotopes in humans. J Nucl Med (1967) 0.75

Vesicle interactions with antibody and peptide hormone: role of vesicle composition. J Nucl Med (1976) 0.75

Studies of radiopharmaceutical-enclosing lipid-protein vesicles formed from native plasma components. J Nucl Med (1977) 0.75

Altered surface glycoproteins in melanoma cell variants with reduced metastasizing capacity selected for resistance to wheat germ agglutinin. Biochem Biophys Res Commun (1980) 0.75

[Proceedings: Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex with the membrane fraction of the extraocular muscle]. Nihon Naibunpi Gakkai Zasshi (1974) 0.75

Scintiphotographic studies of acquired cardiovascular disease. Semin Nucl Med (1973) 0.75

Lipid vesicle interaction with EMT-6 tumor cells and effect on subsequent cell growth. Biochem Biophys Res Commun (1976) 0.75

A method to optimise the use of a grayshade scale in nuclear medicine images. Comput Biomed Res (1976) 0.75

The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology (1976) 0.75

Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. N Engl J Med (1974) 0.75

Albumin-loading effect: a pitfall in saline paper analysis of 99mTc-albumin. J Nucl Med (1974) 0.75